期刊文献+

胃外科实验研究进展

Progress in clinical and basic researches of gastric surgery
原文传递
导出
摘要 随着基因组学和影像组学的发展, 以及大数据及人工智能的问世, 胃外科治疗逐渐步入精准医学。胃癌精准外科治疗是以分子诊断和成像技术对胃癌的精准分型和分期为基础, 制定有效且精确的个体化诊治方案, 并将微创手术和快速康复贯穿其中的诊疗理念。为实现上述精准诊疗, 需继续研究胃癌的肿瘤基因组学、肿瘤微环境、肿瘤干细胞、细胞自噬与死亡等新兴热点, 探索腹腔镜手术、机器人手术系统和吲哚菁绿示踪技术等新兴微创技术, 以及化疗、免疫和靶向治疗等综合治疗方案。 With the development of genomics and imaging genomics,the introduction of big data and artificial intelligence,gastric surgical treatment has gradually stepped into precision medicine.Precision surgical treatment of gastric cancer is based on the accurate molecular typing and staging of gastric cancer by molecular diagnostic and imaging technologies,the formulation of effective and precise individualized diagnostic and treatment plans,and the concept of minimally invasive surgery and rapid rehabilitation throughout the diagnosis and treatment.To realize the above precise diagnosis and treatment,it is necessary to continue to study the emerging hotspots of gastric cancer,such as tumor genomics,tumor microenvironment,tumor stem cells,cell autophagy and death,and to explore the emerging minimally invasive techniques,such as laparoscopic gastric cancer surgery,robotic surgical system,and indocyanine green tracer technology,as well as the comprehensive treatment approaches,including chemotherapy,targeting and immunotherapy.
作者 玄一 陈永元 刘凤林 Xuan Yi;Chen Yongyuan;Liu Fenglin(The Second Department of Gastric Surgery,Fudan University Shanghai Cancer Center,Department of Oncology,Shanghai Medical College,Fudan University,Shanghai 200032,China;Department of Gastric Surgery,Fudan University Shanghai Cancer Center(Xiamen Branch),Xiamen 361026,China)
出处 《中华实验外科杂志》 CAS 2024年第2期201-208,共8页 Chinese Journal of Experimental Surgery
基金 国家自然科学基金面上项目(82172803、82373381)。
关键词 胃癌 人工智能 精准治疗 Gastric cancer Artificial intelligence Precision medicine
作者简介 通信作者:刘凤林,Email:fenglinliu@hotmail.com。
  • 相关文献

参考文献3

二级参考文献78

  • 1Lauren P. The two histological main types of gastric carcinoma:diffuse and so-called intestinal-type carcinoma. an attempt at ahisto-clinical classification. Acta Pathol Microbiol Scand 1965; 64:31-49 [PMID: 14320675].
  • 2Yuasa Y. Control of gut differentiation and intestinal-type gastriccarcinogenesis. Nat Rev Cancer 2003; 3: 592-600 [PMID:12894247 DOI: 10.1038/nrc1141].
  • 3Chiaravalli AM, Klersy C, Vanoli A, Ferretti A, Capella C, SolciaE. Histotype-based prognostic classification of gastric cancer.World J Gastroenterol 2012; 18: 896-904 [PMID: 22408348 DOI:10.3748/wjg.v18.i9.896].
  • 4Grabsch HI, Tan P. Gastric cancer pathology and underlyingmolecular mechanisms. Dig Surg 2013; 30: 150-158 [PMID:23867592 DOI: 10.1159/000350876].
  • 5Wang K, Kan J, Yuen ST, Shi ST, Chu KM, Law S, Chan TL,Kan Z, Chan AS, Tsui WY, Lee SP, Ho SL, Chan AK, Cheng GH,Roberts PC, Rejto PA, Gibson NW, Pocalyko DJ, Mao M, XuJ, Leung SY. Exome sequencing identifies frequent mutation ofARID1A in molecular subtypes of gastric cancer. Nat Genet 2011;43: 1219-1223 [PMID: 22037554 DOI: 10.1038/ng.982].
  • 6Zang ZJ, Cutcutache I, Poon SL, Zhang SL, McPherson JR, TaoJ, Rajasegaran V, Heng HL, Deng N, Gan A, Lim KH, Ong CK,Huang D, Chin SY, Tan IB, Ng CC, Yu W, Wu Y, Lee M, Wu J,Poh D, Wan WK, Rha SY, So J, Salto-Tellez M, Yeoh KG, WongWK, Zhu YJ, Futreal PA, Pang B, Ruan Y, Hillmer AM, BertrandD, Nagarajan N, Rozen S, Teh BT, Tan P. Exome sequencing ofgastric adenocarcinoma identifies recurrent somatic mutations incell adhesion and chromatin remodeling genes. Nat Genet 2012;44: 570-574 [PMID: 22484628 DOI: 10.1038/ng.2246].
  • 7Lee YS, Cho YS, Lee GK, Lee S, Kim YW, Jho S, Kim HM, HongSH, Hwang JA, Kim SY, Hong D, Choi IJ, Kim BC, Kim BC, KimCH, Choi H, Kim Y, Kim KW, Kong G, Kim HL, Bhak J, Lee SH,Lee JS. Genomic profile analysis of diffuse-type gastric cancers.Genome Biol 2014; 15: R55 [PMID: 24690483 DOI: 10.1186/gb-2014-15-4-r55].
  • 8Shern JF, Chen L, Chmielecki J, Wei JS, Patidar R, RosenbergM, Ambrogio L, Auclair D, Wang J, Song YK, Tolman C, HurdL, Liao H, Zhang S, Bogen D, Brohl AS, Sindiri S, CatchpooleD, Badgett T, Getz G, Mora J, Anderson JR, Skapek SX, BarrFG, Meyerson M, Hawkins DS, Khan J. Comprehensive genomicanalysis of rhabdomyosarcoma reveals a landscape of alterationsaffecting a common genetic axis in fusion-positive and fusionnegativetumors. Cancer Discov 2014; 4: 216-231 [PMID:24436047 DOI: 10.1158/2159-8290.CD-13-0639].
  • 9Sieren JC, Meyerholz DK, Wang XJ, Davis BT, Newell JD,Hammond E, Rohret JA, Rohret FA, Struzynski JT, GoekenJA, Naumann PW, Leidinger MR, Taghiyev A, Van Rheeden R,Hagen J, Darbro BW, Quelle DE, Rogers CS. Development andtranslational imaging of a TP53 porcine tumorigenesis model.J Clin Invest 2014; 124: 4052-4066 [PMID: 25105366 DOI:10.1172/JCI75447].
  • 10Wang K, Yuen ST, Xu J, Lee SP, Yan HH, Shi ST, Siu HC, Deng S,Chu KM, Law S, Chan KH, Chan AS, Tsui WY, Ho SL, Chan AK,Man JL, Foglizzo V, Ng MK, Chan AS, Ching YP, Cheng GH, XieT, Fernandez J, Li VS, Clevers H, Rejto PA, Mao M, Leung SY.Whole-genome sequencing and comprehensive molecular profilingidentify new driver mutations in gastric cancer. Nat Genet 2014;46: 573-582 [PMID: 24816253 DOI: 10.1038/ng.2983].

共引文献249

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部